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Abstract
Quality control (QC) is the most important key issue in the pharmaceutical industry to ensure the quality of drug
products. Many analytical instruments and techniques in pharmaceutical analysis are applied to assess the quality and
quantity of the drugs. In the current and future trends, a combination of digitization, automation and hyphenation with
high throughput on-line performance will be the topics for the future of pharmaceutical QC. The hyphenated analytical
techniques have recently received great attention as unique means to solve complex analytical problems in a short period
of time. This review article is an update on the recent potential applications of hyphenated technique developed from
the coupling of a rapid separation or induction technique (differential scanning calorimetry; DSC) and an on-line
spectroscopic (Fourier transform infrared; FTIR) detection technology to carry out an one-step solid-state analysis in
pharmaceutical formulation developments, including (1) intramolecular condensation of pharmaceutical polymers, (2)
intramolecular cyclization of drugs and sweetener, (3) polymorphic transformation of drugs and excipients, (4) drugpolymer (excipient) interaction, (5) fast cocrystal screening and formation. This simultaneous DSC-FTIR microspectroscopy can also provide an easy and direct method for one-step screening and qualitative detection of drug stability in real time.
Keywords: DSC-FTIR microspectroscopy, Hyphenation, One-step, Real time, Solid-state analysis

1. Introduction
ccording to the “Quality Guidelines” of
ICH for the development of pharmaceutical drug products, understanding the physicochemical properties of active pharmaceutical
ingredients (APIs) and excipients is an important
prerequisite for successful development and
manufacture of different dosage forms [1,2]. The
physicochemical properties of both APIs and excipients include particle size, powder properties,
moisture content, hygroscopicity, crystal properties, solubility, polymorphs, stability and their
compatibility [3e5]. These properties play a
crucial role in pharmaceutical development; it
must pay more attention in the pharmaceutical
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manufacturing processes [6e9]. Moreover,
several manufacturing factors such as temperature, light, humidity, pressure, processing time,
and solvents used have found to inﬂuence the
solid-state characteristics of APIs and excipients,
leading to alterations of the physicochemical
properties, bioavailability and therapeutic efﬁcacy
of the APIs [10e12].
From the ICH guidance and US FDA regulation
for drug development and manufacturing, a
detailed characterization of the critical physical attributes of the pharmaceutical materials should
make sure to comply with regulatory requirements
[13,14]. It has been known that the solid state characterization of pharmaceutical solids can be
analyzed by several analytical techniques [15e21].
Brittain et al. classiﬁed the physical properties of
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Table 1. Classiﬁcation of physical characterization of pharmaceutical solids by various analytical approaches [Modiﬁed, with permission from Ref.
[15]].
Molecular level

Particulate level

Bulk level

Spectroscopies
Light Microscopy
UVevis spectroscopy (UV-VIS)
Fluorescence spectroscopy
Fourier transform infrared spectroscopy (FTIR)
Raman spectroscopy
Near-infrared spectroscopy (NIR)
Solid-state nuclear magnetic resonance
spectrometry (SSNMR)

Spectroscopies
Terahertz pulsed spectroscopy (TPS)
Terahertz Pulsed imaging (TPI)
Fluorescence spectroscopy
Dielectric spectroscopy
X-ray photoelectron spectroscopy (XPS)
Single-crystal X-ray diffraction (SCXRD)
Particle morphology
Polarized light microscopy (PLM)
Scanning electron microscope (SEM)
Atomic force microscope (AFM)
Transmission electron microscopy (TEM)
Particle size/distribution
Particle size analyzer
Diffractometry
Powder x-ray diffraction (PXRD)
Thermal analysis
Thermogravimetric analysis (TGA) Differential
scanning calorimetry (DSC)
Modulated differential scanning calorimetry (MDSC)
Hot-stage microscopy (HSM)
Zeta potential analyzer

Micromeritics
Powder characteristics tester
 Angle of repose
 Cohesion
 Aerated density
 Uniformity
 Dispersibility
 Compressibility
 Angle of Fall
 Packed density
 Angle of Spatula
 Angle of difference
 Particle size
Powder ﬂow analyzer
Gas pycnometry
Moisture analyzer
Wall friction tester
Tensile tester
Contact angle goniometer

pharmaceutical solids into three main levels: (1)
molecular level (properties associated with individual inorganic or organic molecules), (2) the particulate level (properties belonged to individual
geometrical solid particles), and (3) the bulk level
(properties associated with particulate assemblies)
[15,19]. Table 1 lists the classiﬁcation of physical
characterization of pharmaceutical solids by various
analytical approaches [15,17,19], in which the
molecularelevel properties are usually evaluated by
using vibrational spectroscopy and solid-state nuclear magnetic resonance spectrometry (SSNMR);
the particulate level properties are determined by
particle morphology, particle size/distribution,
thermal and diffractometric methods; and the bulk
level properties are focused on surface area,

porosity and pore size distribution, and powder ﬂow
characteristics [15,21e23].
Since many APIs can exist in different pharmaceutical solid forms, the solubility, ﬂowability,
compressibility, physical and chemical stability, and
reactivity of these APIs may be altered depending
on manufacturing processes and/or under storage
conditions of the ﬁnal solid dose forms. Scheme 1
illustrates the manufacturing processes affecting
solid state characterization of drug substances.
Therefore, selecting an optimal solid form of an API
is of considerable importance and also a key factor
to maintain the selected solid form through formulation development, scale up, manufacturing processes, storage and usage of drug products.
Particularly, the possibility of compatibility/

Scheme 1. Manufacturing processes affecting solid state characterization of drug substances.

REVIEW ARTICLE

183

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

184

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

REVIEW ARTICLE

interaction, and API stability after exposure to
elevated humidity and temperature over time
should be conducted [24e27]. It is therefore necessary to use the comprehensive solid-state analytical
approaches for ensuring and maintaining maximum
quality control of an original API in pharmaceutical
drug products [6,28,29].

2. The most commonly used solid-state
analysis of APIs in drug products
Newman and Byrn had reported that the solid
APIs played an important role to impact the quality
and consistency of the ﬁnal solid oral dosage formulations [29]. Thus how to monitor and/or control
the intact solid API continuously existed in drug
product without any change from development to
market and beyond is the most critical factor for
successful drug development in the pharmaceutical
industry [30e32]. In common, it is necessary to
analyze each raw API, intermediate and ﬁnal
ﬁnished product at designated times to ensure the
highest quality during pharmaceutical process
development for supporting the regulatory ﬁling
activities [33,34]. Until now, many analytical techniques such as thermal, spectroscopic, and diffractometric methods have been often used to
determine and conﬁrm the original crystal form of
API still existed in solid dosage forms after different
pharmaceutical
manufacturing
processes
[29e31,33e35]. Several unusual drug examples on
the market had occurred undesired solid state conversion, resulting in poor bioavailability related
problems or clinical failures [36,37].
Here, three most commonly used analytical techniques including thermal, spectroscopic, and
diffractometric methods for solid-state analysis of
APIs and drug products will be brieﬂy described as
follows.
2.1. Thermal analysis
Thermal analysis (TA) is one of the oldest analytical techniques for studying the thermal properties
of different materials as a function of temperature or
time [38,39]. In the ﬁeld of pharmaceutical research,

TA has been often applied to investigate and characterize different pharmaceutical substances, such as
physical stability (e.g., weight loss, loss of hydration/
solvation, degradation and/or decomposition), phase
transitions (e.g., melting, sublimation, polymorph
conversion) and other complex phenomena (e.g.,
chemical reaction, vitriﬁcation, relaxation, etc.)
[40e44]. Four common TA techniques used in the
pharmaceutical ﬁelds are thermogravimetric analysis (TGA), differential thermal analysis (DTA), differential scanning calorimetry (DSC), and
thermomechanical analysis (TMA). The primary
differences in these TA techniques and the properties measured of the materials are listed in Table 2.
Hot-stage microscopy (HSM) is an another thermal
method and can be used to visually examine many
kinds of thermal transitions such as melting point,
melting range, crystal nucleation, crystal growth,
crystal transformations and others under a microscope, especially for the study of the visual color
changes in the process of thermal transitions [45,46].
2.2. Vibrational spectroscopic technique
The vibrational spectroscopy commonly includes
mid-infrared (MIR), near-IR (NIR), and Raman
spectroscopy. Fourier Transform Infrared (FTIR)
spectroscopy is mainly used to measure MIR light
absorption (wavelengths 2.5e25 mm). Both FTIR and
Raman spectroscopies are complementary techniques, and offer rapid and non-invasive analysis to
provide speciﬁc ﬁngerprinting spectra for analysis
of molecules in different scientiﬁc and industrial
ﬁelds [47e50]. These techniques are indispensable
analytical techniques in pharmaceutical analysis
and can substantially identify and characterize the
drug substances and excipients in drug discovery
and formulation development, as well as in on-line
pharmaceutical process manufacturing [51e54].
Both FTIR and Raman spectroscopies provide
characteristic fundamental vibrations and are
applied to the elucidation of molecular structure,
whereas NIR spectroscopy is based on molecular
overtones and combinations of vibrational modes to
measure the absorption of electromagnetic radiation
within wavelengths from 750 to 2500 nm [55e58].

Table 2. Conventional TA techniques and the representative properties measured for materials.
TA Technique

Abbreviation

Representative properties measured

Thermogravimetric analysis
Differential thermal analysis
Differential scanning calorimetry
Thermomechanical analysis
Hot stage microscope

TGA
DTA
DSC
TMA
HSM

Decomposition, oxidation or loss of solvent or water
Melting points, glass transitions, phase changes
Melting points, heats of reaction, glass transition, heat capacity
Expansion, contraction, penetration, softening, glass transition
Thermal transition/crystal growth (Visual color change)

On the other hand, NIR spectroscopy as a powerful
technique has recently been used for monitoring
end-point of many pharmaceutical manufacturing
processes, such as granulation, mixing or drying,
since the NIR measurement not only requires no or
little sample preparation but also is fast for online
process control [59,60].
In recent years, two new techniques of Terahertz
Pulsed spectroscopy (TPS) and Terahertz Pulsed
imaging (TPI) instruments are now commercially
available for rapid and non-destructive analysis in
pharmaceutical industry [61,62]. Both Terahertz
techniques have been availably used for various
pharmaceutical applications, such as (1) discrimination and quantiﬁcation of polymorphism and
crystallinity, (2) analysis of solid form transformation dynamics, (3) quantitative characterization of tablet ﬁlm coatings: off-line and on-line, (4)
tablet porosity measurement, (5) tablet coating and
dissolution, (6) spectroscopic imaging and chemical
mapping [61e66]. Fig. 1 shows different frequency
ranges of the electromagnetic spectrum [67].
2.3. Diffractometric technique
X-ray diffraction (XRD) is a nondestructive technique used in solid state chemistry to characterize
both organic and inorganic crystalline materials in
various ﬁelds, as indicated in Fig. 2 [68,69]. XRD has
a tremendous potential for solid state drug analysis
in all stages of drug discovery and development,
manufacturing and quality control of manufactured
pharmaceutical products, in which XRD may
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Fig. 2. Analytical applications of X-ray diffraction (XRD) in different
ﬁelds [Reproduced from Ref. [68]].

provide more valuable pharmaceutical information
on crystal structure, polymorphism, and degree of
crystallinity and amorphous character of solid formulations, excipient compatibility, detection of impurities formed, stability studies, dosage uniformity,
and manufacturing process control [70e72]. XRD is
mainly based on Bragg's law, 2dsinq ¼ nl, Where d is
the spacing between diffracting planes, q is the
incident angle, n is an integer, and l is the beam
wavelength.
XRD
patterns
result
from

Fig. 1. Different frequency ranges of the electromagnetic spectrum [Modiﬁed, with permission from Ref. [67]].
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electromagnetic waves impinging on a regular array
of scatters, as shown in Fig. 1 [67]. The XRD pattern
is the ﬁngerprint of periodic atomic arrangements in
a given material and commonly employed on thick
or powdered materials due to its penetration depth
of X-ray, resulting in the enhanced performance for
detection of internal structural properties of the
material [73].
The XRD analyzer consists of three key elements,
X-ray source, a sample, and a detector, to pick up
the diffracted X-rays [69]. Several scattering techniques of X-ray crystallography have been reported:
single-crystal diffraction, powder diffraction, ﬁber
diffraction, small-angle and wide-angle X-ray scattering [74]. Two major techniques, powder X-ray
diffraction (PXRD) and single-crystal X-ray diffraction (SCXRD), are the most common approaches
used in pharmaceutical investigation [75,76].
PXRD can characterize the structural properties of
powders or microcrystalline solid materials,
whereas SCXRD may determine three dimensional
arrangements of atoms in a crystalline chemical
compound. Particularly, PXRD has always applied
to the pharmaceutical industry via solid-state analysis of a drug substance or product in various stages
of drug development and manufacturing process as
follows: (1) API characterization and excipient
identiﬁcation (phase analysis and polymorph
screening, crystallinity determination, control of
ingredients), (2) determination of physical and
chemical stability (compatibility studies, stability
studies), (3) monitoring for solid form conversion
upon
manufacturing
(process
control,
manufacturing and production), (4) veriﬁcation of
the solid form of the API in the drug product (batch/
dosage uniformity, impurities product) [77e80].

3. Hyphenated analytical techniques applied
to pharmaceutical analysis
In recent years, hyphenated analytical techniques
have received considerable attention as unique
analytical tools for solving various complex problems in pharmaceutical analysis [81e85]. The merits
of hyphenated analytical techniques have remarkably broadened their applications in the analysis of
biomaterials, natural products, cosmetics, pharmaceuticals and biomedical products. The hyphenated
technique simply connects two or more analytical
instruments together to enhance material characterization with an appropriate interface [86]. The
term “hyphenated techniques” may range from the
combination of separationeseparation, separationidentiﬁcation and identiﬁcationeidentiﬁcation techniques [87]. The hyphenated analytical method has

been able to provide faster and more reliable results
than that a traditional single instrumental method.
The technique developed by coupling a separation technique and an on-line spectroscopic detection (identiﬁcation) technology is the most used
hyphenated technique, thus Patel et al. had
discussed the use of ﬁve available hyphenated
techniques, e.g., gas chromatographyemass spectroscopy (GCeMS), liquid chromatography-Fourier
transform infrared (LC-FTIR), LC-MS, LC-nuclear
magnetic resonance spectroscopy (LC-NMR),
capillary electrophoresis-MS (CE-MS), for preisolation analyses of crude extracts or fraction from
various natural sources, isolation and on-line
detection of natural products, chemotaxonomic
studies, chemical ﬁngerprinting, quality control of
herbal products, and etc. [81]. The GC, LC and CE
were as the separation tool in the hyphenated
techniques, whereas FTIR, MS and NMR were utilized as identiﬁcation tool. The combination of both
separation tools with identiﬁcation techniques has
been demonstrated for years to qualify and quantify
the unknown compounds in complex natural
product extracts or fractions [81].
Ermer and Vogel had successfully introduced the
applications of hyphenated LC-MS techniques in
pharmaceutical analysis, in which LC-MS might
systematically be applied to monitor and identify
the impurity proﬁles during pharmaceutical development and scaling up for supporting the safety
evaluation of batches used in clinical studies [88]. In
addition, Pan et al. had reviewed and discussed the
current analytical strategies for chemical and
structural identiﬁcation of pharmaceutical impurities [89]. Because the pharmaceutical impurities
had pharmacological or toxicological effect, the
presence of these impurities and their levels in drug
products often had critical impacts on the quality of
drug products and the safety of patients. Thus understanding drug impurities or drug degradation
products in the formulated products must be conducted. The LC-MS had been widely used in the
pharmaceutical industries due to its excellent
sensitivity for the detection of trace level of impurities and degradation products observed in
formulated dosage forms. Sometimes, other hyphenated analytical techniques such as LC-NMR,
GCeMS, and size-exclusion chromatography
(SEC)/chemiluminescent nitrogen detectors (CLND)
were also used to identify and conﬁrm the ﬁnal
structures of impurities as required during dosage
form development.
In addition, the identiﬁcationeidentiﬁcation
modes of hyphenated techniques had also been
applied to polymeric and pharmaceutical industries

by coupling TA techniques with spectroscopic
technique [90e96]. TA techniques were commonly
well-established techniques used for characterization of polymers and pharmaceuticals. A single TA
technique simply measured the change of a speciﬁc
property of materials as a function of temperature,
whereas the hyphenated techniques coupled with
different analytical techniques and equipped with a
proper interface could enable user to determine
more
information
from
complex matrices
[44,83,87,96]. Therefore, the application of the hyphenated analytical techniques in pharmaceutical
analysis has offered great advances [84e88,97e101].

4. Simultaneous DSC-FTIR microspectroscopy
It had been reported that TA techniques could
only measure the physical properties of materials; it
was often incomplete and/or limited in its ability to
address chemical composition and structure [102].
In order to overcome the limitation of TA techniques, coupling TA instruments with chromatographic or spectral instruments to increase the
information collected during the experiment is one
of the most important challenges [83e87,103].
Analysis of complex samples has been greatly
assisted by the coupling of FTIR analysis to the TA
experiment [91,94]. The combination of DSC and
FTIR spectroscopy gives important spectroscopic
and thermodynamic information for a solid or liquid
sample upon heat treatments [90e94]. The DSCFTIR technique is being more widely recognized as
a powerful tool for understanding the thermaldependent structural behaviour. The most promising research areas are probably polymers and the
polymorphism of pharmaceuticals [90,91,94].
4.1. Introduction of DSC
DSC is a fundamental tool and also the most
commonly used TA tool for investigating the temperature-driven phase changes of different materials. DSC can measure the transition such as the
melting, crystallization, and glass transition of materials from polymers to foods and to pharmaceuticals [22,38e43]. DSC not only measures directly
the endothermic or exothermic behavior of a material as a function of temperature, but also provides
qualitative and quantitative information of thermodynamic parameters such as glass transition temperature
(Tg),
melting
temperature
(Tm),
crystallization temperature (Tc), and thermal properties such as the enthalpy (H ), heat capacity (Cp)
[38e43,104]. However, Menard et al. pointed out
that DSC lacked structural or chemical information
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from its DSC thermogram [102,103], in which DSC
only provided the thermal properties of solid materials. The structural or chemical information of
solid samples must be obtained from other analytical methods.
4.2. DSC coupling with FTIR spectroscopy
Although DSC is a well-known analytical tool to
measure the temperature-dependent phase changes
and various kinetic parameters, it is also used to
combine with a few analytical instruments only so
far. DSC has only been found in conjunction with
FTIR spectroscopy (DSC-FTIR), mass spectrometry
(DSC-MS) or X-ray diffraction [90,91,105e108]. Two
simultaneous DSC-FTIR combined systems had ﬁrst
been studied in 1986 by two groups of researchers to
examine the structural changes of polypropylene
during melting or to monitor the morphological
transitions on the hydrogen bonding of polyurethanes, respectively [90,105].
The DSC coupling with FTIR spectroscopy deals
with the thermal and spectral information to be
derived simultaneously from a single sample. This
simultaneous DSC-FTIR technique gives thermodynamic and spectroscopic information about a
solid or liquid sample upon thermal treatment
[44,90,91,105], in which DSC measured the endothermic and/or exothermic responses of the samples, while the FTIR analysis detected thermal
changes in chemical and physical compositions. The
possible merits of this DSC-FTIR combined system
may be proposed as follows: (1) the same sample for
both determinations; (2) the identical thermal and
chemical environments; (3) real time response to
both thermal and chemical events, and (4) a short
analysis time [109]. Therefore, this DSC-FTIR
coupled technique can be used easily and effectively
to study the thermal and spectral properties of
pharmaceuticals in real time.
4.3. DSC-FTIR instrument conﬁguration
As described above, the hyphenation of DSC with
FTIR microspectroscopy had ﬁrst been used in 1986
[90,105]. This DSC-FTIR combined technique can
simultaneously provide the thermodynamic and
spectroscopic information of the sample under
thermal treatment at the same time. In this
approach, the whole instrument of DSC-FTIR
microspectroscopic system used in my laboratory is
shown in Fig. 3. This DSC-FTIR combined system
involves the use of a miniature DSC cell positioned
under the objective of an IR microscope in
conjunction with FTIR spectroscopy. A computer
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Fig. 3. The instrumental conﬁguration of a DSC-FTIR microspectroscopic apparatus [Modiﬁed, with permission from Ref. [44]].

directly monitors DSC and FTIR analyses, and the
overall operation permits the simultaneous collection of both data sets. In this combined system, DSC
can measure the thermal responses of the samples,
whereas FTIR analysis determines the changes in
their structure simultaneously.
This FTIR microspectroscopy is commonly
equipped with mercury cadmium telluride (MCT)
as a detector in the narrow and mid-band wavelength range between 4000 and 650 cm1. The
FTIR spectra are generated by co-addition of 256
interferograms collected at 4 cm1 resolution. The
MCT detector used with an IR microscope has a
much greater sensitivity, which is suited to the
measurement of micrometer sized samples common for microscopic measurements. However, the
MCT detector has some disadvantages such as the
requirement for liquid nitrogen cooling for measurements, a reduced absorbance linearity and a
reduced wavenumber range for measurements.
Recently, a new deuterated L-alanine triglycine
sulphate (DLATGS) detector has been developed
for IR microscopy with wide wavenumber range
between 4000 and 450 cm1 at ambient temperatures to meet various measurement purposes,
especially focusing on an increased sensitivity
[110].
In my laboratory, the hot stage microscopy is used
as a DSC cell, which is a precise thermal measurement cell for simultaneous visual observation and
heat ﬂow measurements. In the instrument conﬁguration, the IR beam passes through a hole in the
DSC cell via the IR microscope to the MCT detector.
The samples are generally mounted on an optically
transparent medium of potassium bromide (KBr)
pellet and then placed it in a hole in the DSC cell,
which can be used as the transmission or reﬂectance
mode. A careful alignment procedure is required

prior to the operation. This simple and time-saving
system relies on a one-step continuous process and
provides the correlation between thermal response
and spectral information regarding structural
changes occurring in the sample. Moreover, this
combined system may also be acted as an accelerated stability testing apparatus to predict the thermal stability of samples. This unique DSC-FTIR
combined system has been extensively applied to
quickly investigate the thermal-induced structural
changes and stability of foods, polymers, pharmaceuticals, excipients, and cocrystal formation
[44,99,111].
4.4. DSC-FTIR microspectroscopy for rapid solidstate analysis of drugs and pharmaceutical
polymers or excipients
The solid-state chemistry of drugs has received
major attention from the pharmaceutical industry
and has become an increasingly important benchmark in drug development because solid-dosage
forms are the most commonly used preparations
[98,99]. A better understanding of solid state properties of an API is essential for pharmaceutical drug
development and should be the ﬁrst priority in the
design of oral solid dosage drugs. This DSC-FTIR
microspectroscopy can simultaneously establish the
correlation between the thermal response and the
IR spectral information of structural changes of the
drug sample. This technique not only can simulate
the accelerated stability test, but also may simultaneously detect the decomposed products in real
time. The current review attempts to provide a
succinct update of DSC-FTIR microspectroscopy
used on the investigation of the solid state analysis
of different drugs and polymers or excipients (Table
3), the details are as follows.

Table 3. A DSC-FTIR microspectroscopy used for investigation of the solid state analysis of different drugs and polymers or excipients.
Intramolecular
condensation

Intramolecular cyclization
(DKP formation)

Polymorphic
transformation

Drug-polymer (excipient)
interaction

Cocrystal screening
and formation

Silicone elastomer
(Ref. [112])
Eudragit L
(Ref. [113e115])
Eudragit E
(Ref. [116])

Lisinopril dihydrate
(Ref. [130])
Enalapril Maleate
(Ref. [131,132])
Aspartame hemihydrate
(Ref. [133,134])

Eudragit L-theophylline
(Ref. [163])
Eudragit E-enalapril maleate
(Ref. [164])
Asparagine-glucose
(Ref. [165])

Carbamazepine-glutaric acid
(Ref. [188])
Indomethacin-saccharin
(Ref. [188-184,194])
Theophylline-citric acid
(Ref. [190,191])

Eudragit S
(Ref. [117])

Gabapentin
(Ref. [138])

Acetaminophen
(Ref. [147,148])
Famotidine
(Ref. [149])
Metoclopramide
HCl monohydrate
(Ref. [150,151])
Indomethacin
(Ref. [152,153])

Metoclopramide HCl
monohydrate-KBr
(Ref. [166])
Human serum albumin
(HSA)-ribose
(Ref. [167])

Metaxalone-succinic acid
(Ref. [192])

Eudragit L30D
(Ref. [117])

Trehalose dihydrate
(Ref. [154])

Carbopol
(Ref. [117])

Rafﬁnose pentahydrate
(Ref. [155])

PVA copolymer
(POVACOAT)
(Ref. [119])

Captopril
(Ref. [160])

4.4.1. Solid-state intramolecular condensation of
pharmaceutical polymers
Lin et al. used a DSC-FTIR microspectroscopy to
examine the curing kinetics of silicone elastomer via
intramolecular condensation [112]. This DSC-FTIR
microspectroscopy was a very rapid and convenient
apparatus for determination of the curing kinetics of
medical grade silicone elastomer (MDX-4-4210), in
which the change in IR peak intensity of SieH at
2162 cm1 for the curing agent might be acted as a
reaction marker. The IR peak intensity of the SieH
band was decreased with the increase in temperature during curing process, which might be attributed to the curing reaction occurred between SieH
(curing agent) and CH2]CH2 (elastomer), leading
to reduction of the amount of SieH groups in the
reaction mixture. In addition, the curing temperature and normal hydrocarbon alcohols added
signiﬁcantly inﬂuenced the curing process of silicone elastomer, in which the curing reaction might
be described by ﬁrst-order kinetics.
Lin and co-workers had used DSC-FTIR microspectroscopy to extensively examine an intramolecular interaction occurred in a series of
methacrylic acid copolymers such as Eudragit L, S,
E, RL, RS, L30D, E30D, PVA copolymer, and carbopol by nonisothermal or isothermal method with
transmission or reﬂectance model [113e119]. A 6membered cyclic anhydride formation was respectively produced by heating each Eudragit L, S, E or
L30D, PVA copolymer or carbopol via inter- or
intramolecular ester condensation. Eudragit E as an
example, the anhydride-related IR peak intensities
at 1801 and 1763 cm1 (asymmetric and symmetric

Indomethacin-nicotinamide
(Ref. [193,195])
Piroxicam-saccharin
(Ref. [196])

stretching vibration mode of the C]O group in an
anhydride structure) as well as 1007 cm1 (asymmetric stretching mode of CeOeC for a cyclic anhydride) appeared from 180  C and increased with
the heating temperature, suggesting that the anhydride formation via ester condensation started
above 180  C (Fig. 4) [116]. Moreover, the higher
peak intensity ratio of 1763 cm1/1801 cm1 also
exhibited the predominant role of intramolecular
ester condensation in anhydride formation for
Eudragit E ﬁlm. However, Eudragit RL, RS, or E 30D
polymer revealed a higher thermal-stable behavior
without ester condensation [118]. In addition, the Tg
of different polymers was also easily and rapidly
measured by DSC-FTIR analysis in a short time, as
compared other techniques [120].
4.4.2. Solid-state intramolecular cyclization of drugs
and sweetener
A better understanding of drug stability in various
dosage forms and their regulatory requirements are
essential for pharmaceutical researchers. The intramolecular aminolysis occurred in protein drugs is
also an important stability problem for formulating
these drugs with or without different excipients
[121e123]. The intramolecular cyclization of amino
and carboxylic acid, ester, or amide, groups at the
N-terminus of a peptide or protein, to form diketopiperazine (DKP) is a key degradation pathway
during peptide synthesis or long-term storage
[121e125]. The detailed mechanism of DKP formation from dipeptide amides involves the nucleophilic attack of the N-terminal nitrogen at the amide
carbonyl carbon-atom, between the second and
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Fig. 4. Threeedimensional plots of reﬂectance FTIR spectra of Eudragit E ﬁlm with respect to the temperature (a) and the scheme for six-membered
cyclic anhydride formation via heating process (b) [Modiﬁed, with permission from Ref. [116]].

third amino acids. Until now, several analytical
methods have been used to investigate the stability
and DKP formation of these dipeptide drugs in solid
and liquid states [99,126e129].
A simultaneous DSC-FTIR technique for real-time
induction and detection of DKP formation from the
pharmaceutical dipeptides including lisinopril
dihydrate, enalapril maleate and aspartame hemihydrate had been examined by Lin and colleagues
[99,130e134]. Lisinopril dihydrate as an example,
the threeedimensional plots of FTIR spectra of
lisinopril dihydrate as a function of temperature
between 3700e2500 and 1800e1200 cm1 of wavenumbers is displayed in Fig. 5 [130]. A new peak at
1670 cm1 assigned to the carbonyl band of DKP
formation was clearly evidenced. The water of reaction byproduct was liberated at a temperature
>100  C and appeared on the IR spectra near 32003400 cm1. Moreover, the peak at 1574 cm1
assigned to carboxylate was shifted to 1552 cm1
due to the DKP formation. The peak intensity at
1670 cm1 related to the DKP formation was
changed slightly from 147  C but signiﬁcantly above
157  C. Because both DSC and TGA methods are
hard to show up lisinopril DKP formation, the DSCFTIR microscopic system can be considered to be a
useful technique to quickly and directly detect the

solid-state stability of drug [130]. The pathway of
two consecutive dehydration processes and intramolecular cyclization of DKP formation in solidstate lisinopril dihydrate had been examined by this
one-step DSC-FTIR microscopy, as shown in Fig. 6
[130]. The solid-state lisinopril dihydrate exhibited
two step dehydration processes: the ﬁrst process
was from dihydrate to monohydrate at 76  C and
then the second process was from monohydrate to
anhydrate at 99e101  C. The DKP formation was
continuously occurred after 147  C via intramolecular cyclization in solid-state anhydrous lisinopril. The DKP formation might be as an impurity
existed in pharmaceutical dosage forms. Similar
results are also observed for enalapril maleate and
aspartame hemihydrate [131e134].
In addition, Widjaja et al. had successfully used
the multivariate data analysis approach based on
entropy minimization and spectral dissimilarity to
investigate the solid-state kinetics of intramolecular
cyclization of enalapril maleate via thermal FTIR
microscopy [135]. The infrared spectra of enalapril
maleate and DKP were reconstructed. Their kinetic
analysis revealed that the process of degradation
required about 176.4e193.9 kJ/mol of activation energy based on ﬁtting the fraction decomposed of
enalapril maleate to seven nucleation models.
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Fig. 5. Threeedimensional plots of FTIR spectra of solid-state lisinopril dihydrate a function of temperature (a) and temperature-dependent changes in
peak intensity of the selected IR banks of lisinopril dihydrate (b) [Modiﬁed, with permission from Ref. [130]].

Moreover, Tan and Widjaja further interpreted the
pathway of dehydration and intramolecular cyclization of lisinopril dihydrate in the solid state via
isothermal FTIR microscopy by using advanced

multivariate chemometric approach [136,137]. The
estimated activation energy of the intramolecular
cyclization reaction of lisinopril was about 327 kJ/
mol.

Fig. 6. The pathway of two consecutive dehydration processes and intramolecular cyclization pathway of DKP formation in solid-state lisinopril
dihydrate [Modiﬁed, with permission from Ref. [130]].
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The detailed intramolecular lactamization process
of gabapentin (GBP) to form gabapentin-lactam
(GBP-L) was also studied by Hsu and Lin via onestep DSC-FTIR microspectroscopy [138]. This DSCFTIR microspectroscopy clearly evidenced that the
IR spectral peak at 3350 cm1 for water liberated
was found and at 1701 cm1 for lactam structure was
formed due to the lactam formation of GBP. In
addition, the intramolecular lactamization GBP was
easily determined in the GBP sample prepared by
embedding it into 2KBr method rather than 1KBr
method.
4.4.3. Solid-state polymorphic transformation of drugs
and excipients
The polymorphic forms of a drug have a profound
impact on the physicochemical properties like
dissolution and solubility, chemical and physical
stability, ﬂowability and hygroscopicity, resulting in
a signiﬁcant inﬂuence on the stability and bioavailability of drug products [37,139e141]. In recent
years, the change of the polymorphic form of APIs
has frequently caused problems in bioavailability
and clinical failures once it is on the market
[36,37,140e143]. Recently, many some advanced
analytical techniques have been applied to characterize the polymorphs and polymorphic transformation [144e146]. In my researches, this one-step
powerful DSC-FTIR combined system has been
designed to quickly investigate the thermal-induced
polymorphic interconversion processes of drugs
involving acetaminophen, famotidine, gabapentin,
indomethacin, metoclopramide HCl monohydrate,
trehalose dihydrate, rafﬁnose pentahydrate in the
solid state, too [147e155].

Fig. 7. Continuous phase transitional changes in the three-dimensional
FTIR plot of amorphous indomethacin (IMC) in the solid state
[Modiﬁed, with permission from Ref. [153]].

Indomethacin (IMC) as an example, IMC has
several polymorphic forms and one amorphous
form [156]. Fig. 7 displays the continuous phase
transitional changes in the three-dimensional FTIR
results of amorphous IMC measured by the simultaneous DSC-FTIR method [153]. It is evident that
the thermal-related changes in IR peak intensity for
several speciﬁc spectra were clearly observed. These
spectral changes signiﬁcantly differed from that of
the spectral changes for g-IMC (did not change).
Four undulating regions of the IR peak intensities
were obviously observed in the three-dimensional
FTIR contour proﬁle. There were no substantial
changes in the contour proﬁle of sharp IR peaks
before 99  C (amorphous state). Once the temperature was >99  C, all the IR peak intensities were
slightly increased as the temperature was increased
from 99  C to 132  C due to the occurrence of
recrystallization. Beyond 132  C, all the IR spectral
peaks became broader and less intense. However,
the sharp IR peak intensities reappeared at temperatures >152  C. The less intense of IR peaks
within 132 Ce152  C might be due to the fusion of
the recrystallized IMC. The sharp IR peak intensities
above 152  C should be corresponded to the phase
transformation from the molten IMC to a-IMC and
g-IMC. The reappearance of the sharp IR peaks at
1741 and 1714 cm1 was explained by this phenomenon. The thermal-dependent successive
conformational changes of amorphous IMC sample
were directly and clearly evidenced by DSC-FTIR
microspectroscopy.
Another continuous process of solid-state dehydration, amorphization and recrystallization of
metoclopramide hydrochloride monohydrate (MCP
HCl H2O) was also determined by this simultaneous
DSC-FTIR microspectroscopic technique [150,151].
During the thermal treatment, three undulating regions of FTIR spectral peak intensities in the contour
proﬁle displayed a marked change. As shown in
Fig. 8, there was a less signiﬁcant change in the
contour proﬁle before 77  C. Once the heating
temperature was >77  C, all the IR peaks became
broadened and weaker in intensities. However, the
sharp IR peak intensities again appeared at temperatures >148  C. Both weak and less intense IR
peaks from 77 to 148  C might be due to the amorphous formation after quick dehydration of MCP
HCl H2O, which resulted in a random structure in
the crystal lattice. The starting temperature of 77  C
was close to that of the thermal change at 78  C in
the TGA and DSC curves. Given that the amorphous form of MCP HCl is unstable during heating,
it quickly recrystallized near 148  C and sharpened
the IR band from broad shape. Obviously, the
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Fig. 8. Continuous phase transitional changes in the three-dimensional FTIR plot of solid-state metoclopramide hydrochloride monohydrate (MCP
HCl H2O) [Modiﬁed, with permission from Ref. [150]].

thermal-dependent 3D plot of the FTIR spectra
clearly indicated both amorphization and recrystallization processes after dehydration of MCP HCl
H2O in a one-step determination. This suggests
that one-step simultaneous DSC-FTIR microspectroscopy is useful for studying changes in the
progressive processes of dehydration, amorphization and recrystallization of solid-state MCP HCl
H2O.
Lin and Cheng also used a thermal micro-Raman
spectroscopy to determine the phase transformation
of solid-state MCP HCl H2O [157]. Three steps of
phase transformation were dehydration, recrystallization, and new crystal formation, which were
markedly correlated with the endothermic and
exothermic results of DSC study and the observations of HSM. The results generally indicated that
MCP HCl H2O crystals were ﬁrst dehydrated to
form an anhydrous sample, then recrystallized and
transformed to a new crystal form of MCP HCl
anhydrate. Similar studies of famotidine under
different compression pressures or milling processes were also examined by thermal micro-Raman
spectroscopic mapping study [158,159].
Wang et al. also investigated the conformational
isomerization of captopril in the solid state by DSCFTIR microspectroscopy [160]. The results demonstrated that the intact captopril was existed as trans
isomer form in the solid state by intramolecular
hydrogen bonding, but after heating the captopril
sample to >102  C, several new bands at 1720, 1645,
and 1610 cm1 were observed with the increase of
temperature, indicating the coexistence of a cis isomer. However, the cis isomer could transform
gradually to the trans isomer after cooling. The trans

isomer was more stable than the cis isomer, but the
cis isomer was favored at the higher temperature.
4.4.4. Solid-state drug-polymer (excipient) interaction
The drug-excipient compatibility study is an
important topic and process in the pre-formulation
stage of drug development [26,27,161,162], in which
the potential interaction between drug and polymer
or excipient has impacts on the physical, chemical,
bioavailability and stability of the drug dosage
forms. In mylaboratory, the drug-polymer interaction of theophylline and Eudragit L or enalapril
maleate and Eudragit E in the solid state was also
conﬁrmed by using one-step DSC-FTIR microspectroscopy [163,164]. Due to the interaction between theophylline and Eudragit L was occurred,
leading to having a higher glass transition temperature of the cast ﬁlm than that of their physical
mixture or Eudragit L-100 alone. An interaction
between theophylline and Eudragit L-100 was also
found in the physical mixture during DSC heating.
Moreover, the formation of an acid anhydride by a
crosslinking process also took place in Eudragit
L-100 polymer at elevated temperature [163].
On the other hand, the mechanism of solid-state
interaction between enalapril maleate and Eudragit
E was also determined by this unique technique.
When the weight ratio of both components was 1:1,
Eudragit E might interact with the carboxyl group of
maleic acid to exacerbate the degradation of enalapril maleate. However, the excess amount of
Eudragit E might somewhat reduce the degradation
of enalapril, due to the interaction that occurred
between Eudragit E and carboxyl group of enalapril
[164].
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Hwang et al. also used this DSC-FTIR technique
to investigate the stepwise reaction pathway of the
solid-state Maillard reaction between glucose and
asparagine [165]. It clearly found that the successive
reaction products such as Schiff base intermediate,
Amadori product and decarboxylated Amadori
product in the solid-state glucose-asparagine Maillard reaction were simultaneously evidenced by this
one-step DSC-FTIR microspectroscopy. The color
changed from white to yellow-brown to dark brown,
and appearance of new IR peaks conﬁrmed the
formation of Maillard reaction products.
Cheng et al. accidentally found that several new
peaks at 3478, 3345 and 1618 cm1 were gradually
increased their intensities from 60 to 78  C and then
decreased with heating temperature in the threedimensional contour proﬁle of MCP HCl H2O
embedded in KBr pellet via determination with
DSC-FTIR microspectroscopy (Fig. 9). However,
there were no any new peaks found in the threedimensional contour proﬁle of MCP HCl H2O
embedded in KCl pellet [166]. These new IR peaks
formed had been conﬁrmed, due to the
ioneexchange reaction occurred between MCP HCl
H2O and KBr. The possible mechanism of this
ioneexchange reaction might be attributed to the
occurrence between the HCl salt of MCP H2O and a
KBr matrix by heating to yield a mixture of HCl and
HBr salts of the MCP sample in the presence of

hydrated water. The crystal hydrate played an
important role to improve this ioneexchange reaction between MCP HCl and KBr. However, no
ioneexchange reaction occurred between MCP HCl
H2O and KCl or between 150  C-preheated MCP
HCl and KBr. This solid-state ioneexchange reaction was only detected by this powerful DSC-FTIR
microspectroscopy
than
other
conventional
methods.
In order to prevent the advanced glycation end
products (AGEs) formation, the DSC-FTIR combined system as an accelerated method was also
attempted to simultaneously determine the thermal-dependent conformational changes of human
serum albumin (HSA) in the HSA-ribose mixture
and also examined the onset of the structural
transformation from a-helix to b-sheet structures
with or without AGEs inhibitors used [167]. The
results clearly indicated that native HSA had an
onset temperature at 96  C for the irreversible
thermal-induced structural transition from a-helices
to b-sheets; whereas HSA-ribose mixture exhibited
its onset temperature near at 78  C due to the early
occurrence of ribosylation (Fig. 10). However, this
onset temperature for the a-helix to b-sheet transition was gradually changed from 78  C to 96  C by
adding the amount of sodium diclofenac or inositol,
which was closed to that of the onset temperature of
native HSA, implying that the thermal-induced

Fig. 9. Three-dimensional FTIR spectral plots and the thermally dependent changes in IR spectra of several speciﬁc peaks of metoclopramide hydrochloride monohydrate (MCP HCl H2O) prepared in the KBr pellet and its pathway of thermally-induced ioneexchange reaction [Modiﬁed, with
permission from Ref. [166]].
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Fig. 10. Thermal-dependent FTIR spectral changes of native human serum albumin (HSA) (A) and HSA-ribose mixture (B), and the onset for
conformational changes from a-helix to b-sheet (C). [Modiﬁed, with permission from Ref. [167]].

conformational transition from a-helix to b-sheet for
HSA in the HSA-ribose mixture was effectively
prevented by adding AGEs inhibitors (sodium
diclofenac or inositol). This unique DSC-FTIR
combined system could be a useful tool to quickly
screen and evaluate the glycation-induced conformational changes of proteins in a one-step process.
4.4.5. Solid-state real-time cocrystal screening and
formation
The characterization of an API is one of the most
important stages in the preformulation development of a drug product. Unfortunately, not all of
APIs can have ideal properties for their use as a
pharmaceutical drug. Since more poorly water-soluble drug candidates are becoming increasingly
popular in the drug development pipeline, many
pharmaceutical technologies have been applied to
enhance the dissolution and bioavailability of poorly
water-soluble drugs [168e171], in which pharmaceutical cocrystals have recently gained increasing
interest in the pharmaceutical industry [172e175].
Pharmaceutical cocrystals may provide a lot of
desired physicochemical properties and patentability without altering the pharmacological properties, thus cocrystals have recently entered the
scope of drug development within the supramolecular chemistry community [172,176,177]. With the
advent of new regulatory guidance on pharmaceutical cocrystals from US FDA and EMA, pharmaceutical cocrystal as a promising drug candidate has
become one of developing targets in the pharmaceutical industry [178e182].
There are many traditional processes and analytical techniques used for the preparation and identiﬁcation of pharmaceutical cocrystals, however,
these operations take considerable time to screen
and prepare the cocrystals [172e177,183e187]. Here,

Lin and colleagues had ﬁrst and successfully used
this unique DSC-FTIR microspectroscopic approach
to simultaneously and directly screen and detect
pharmaceutical cocrystal formation in the following
systems such as indomethacin-saccharin, indomethacin-nicotinamide,
carbamazepine-glutaricacid, metaxalone-succinic-acid and piroxicamsaccharin [188e199]. This powerful one-step DSCFTIR combined technique provides an easy and
direct method for one-step screening and qualitative detection of cocrystal formation in real time.
Indomethacin (IMC)-saccharin (SAC) cocrystal
formation as an example [188,189,194,199], Fig. 11
shows the DSC curves and FTIR spectra of each
component, physical mixture and solvent-evaporated sample of IMC and SAC. It clearly indicates
that two endothermic peaks at 163 and 229  C were
observed in the DSC curves; both peaks might be
attributed to the melting points of IMC and SAC,
respectively. On the other hand, the solvent-evaporated sample showed an endothermic peak near at
184  C, which was close to the melting point of
IMC-SAC cocrystals at 182.6e184.2  C respectively
reported by Basavoju et al. and Padrela et al.
[200,201]. The FTIR spectra of this solvent-evaporated sample is also displayed in Fig. 11, in which
four unique FTIR peaks at 1734, 1714, 1682 and
1317 cm1 clearly appeared. The ﬁrst three FTIR
peaks were similar to that of the IR positions of
IMC-SAC cocrystals [202], implying that the solvent-evaporated IMC-SAC sample was recognized
as a cocrystal. It is interesting to note that these four
unique FTIR peaks (1736, 1718, 1684, 1319 cm1)
were also directly evidenced from the thermaldependent three-dimensional FTIR spectral contour plot of the physical IMC-SAC mixture determined by a simultaneous DSC-FTIR combined
technique after temperature above 154  C. The
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Fig. 11. The DSC curves and FTIR spectra of indomethacin (IMC), saccharin (SAC), and solvent-evaporated sample of IMC-SAC, as well as thermaldependent 3D FTIR spectral plot of the physical mixture of IMC-SAC [Modiﬁed, with permission from Refs. [189,194]].

appearance of these new IR peaks was due to cocrystal formation between IMC and SAC by
hydrogen bonding [200e202]. This implies that this
powerful DSC-FTIR microspectroscopic system
providing the spectroscopic and thermodynamic
information can easily, directly and simultaneously
produce, screen and detect the IMC-SAC cocrystal
formation in real time.
The other indomethacin-nicotinamide cocrystals,
carbamazepine-glutaric-acid cocrystals, metaxalone-succinic-acid cocrystals and piroxicamsaccharin cocrystals exhibited similar behavior and
can be directly obtained by this one-step simultaneous DSC-FTIR combined technique [188,190e193,
195e199].

5. Conclusions
In the recent years, solid-state chemistry of drugs
is of growing importance in the pharmaceutical industry for developing the useful API and stable
dosage forms [3e5], in which advanced solid-state
analytical approaches play a critical role in pharmaceutical process control to detect and ensure the
maximum quantity of an API in dosage forms
[28,29]. Although many analytical techniques have
been respectively used, the hyphenated analytical
techniques have received ever-increasing attention
in recent years as a special means to solve complex
analytical problems in drug analysis [81e85]. The
hyphenated technique is the combination or the
coupling of the different analytical techniques.
There are many advantages for hyphenated technique, such as shorter analysis time, higher degree
of automation, higher sample throughput, better

reproducibility,
reduction
of
contamination,
enhanced combined selectivity and higher degree of
information [44,83,203].
Among various hyphenated techniques for pharmaceutical analysis, a combination of DSC and FTIR
is a very useful technique for monitoring structural
changes of sample under thermal treatment [91e93].
This unique DSC-FTIR combined technique gives
spectroscopic and thermodynamic information of
samples in the heating process. DSC measures the
exothermic and endothermic responses of the
samples, while the FTIR analysis observes their
structural changes in chemical and physical properties. This powerful DSC-FTIR combined system
has been considerably applied to quickly investigate
the thermal-induced structural changes and stability
of foods, polymers, pharmaceuticals, excipients, and
cocrystal formation [99,110e120,130e134,147e155,
163e167,188e199].
In this review article, a series of DSC-FTIR
microspectroscopic studies had been clearly introduced in the rapid solid-state analysis of pharmaceuticals, polymers and excipients including (1)
intramolecular condensation of pharmaceutical
polymers, (2) intramolecular cyclization of drugs
and sweetener, (3) polymorphic transformation of
drugs and excipients, (4) drug-polymer (excipient)
interaction, (5) fast cocrystal screening and formation. This powerful one-step DSC-FTIR combined
technique provides an easy and direct method for
one-step screening and qualitative detection of
drug stability in real time (Fig. 12). In Fig. 12,
trehalose dihydrate as a representative example for
quick DSC-FTIR microspectroscopic study. An IR
peak intensity at 1687 cm1 corresponded to the
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Fig. 12. The schematic ﬂowchart of one-step simultaneous DSC-FTIR microspectroscopic analysis [Modiﬁed, with permission from Ref. [154]].

bending vibration mode of the solid-like water in
trehalose dihydrate decreased sharply at 64  C.
Simultaneously, another IR peak intensity at
1640 cm1 due to the bending of liquid water
quickly appeared and remained constant after
64  C (left). This transitional temperature reﬂected
the thermal-dependent transformation from solidlike water to liquid water in the trehalose dihydrate
structure in the process of dehydration. A
declining peak at 1687 cm1 and a rising peak at
1640 cm1 were only observed simultaneously
from the DSC-FTIR microspectroscopic study in
real time (right) [154].
In the near future, the hyphenated analytical
technique will become an extremely versatile tool
in pharmaceutical analysis by combining several
analytical methods with automation and highthroughput (HT) analysis. Such hyphenation can
enable simultaneous separation, identiﬁcation,
qualiﬁcation and quantiﬁcation of pharmaceutical
components. Different hyphenated systems may be
applied to solve many sophisticated analytical
problems in various ﬁelds [82,85,92,204]. In the
future mission, an integrated approach to ensuring
sustainable development of HT analytical architecture and system can be introduced by an
innovative technology, advanced equipment and
new methodology with high-performance artiﬁcial
intelligence (AI) systems to produce more accurate
and reliable hyphenated instruments and measurements for pharmaceutical researchers in the
pharmaceutical investigations and drug analysis
[205e207].

Acknowledgments
I would like to express my profound gratitude to
all research colleagues for their contributions in the
DSC-FTIR microspectroscopic studies and also
thanks the Ministry of Science and Technology
(MOST), Taiwan, for research funding support in
several studies (NSC-95-2320-B-075-002-MY2; NSC100-2320-B-264-001-MY3; MOST 103-2320-B-264002-MY2.)

Funding
A series of works were partially supported by
Ministry of Science and Technology (MOST), Taiwan.

Conﬂict of interest
The author declares that there is no conﬂict of
interest.

References
[1] ICH
Guidelines.
https://www.ich.org/page/qualityguidelines.
[2] Pramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development: a quality by design
approach. Int J Pharm Investig 2016;6:129e38.
[3] Jones TM. Preformulation studies. In: Tovey GD, editor.
Pharmaceutical formulation: the science and technology of
dosage forms. RSC Pub.; 2018. p. 1e41.
[4] Chaurasia G. A review on pharmaceutical preformulation
studies in formulation and development of new drug molecules. Int J Pharma Sci Res 2016;7:2313e20.
[5] Byrn SR, Zograﬁ G, Chen XS. Solid-state properties and
pharmaceutical development. In: Byrn SR, Zograﬁ G,
Chen XS, editors. Solid-state properties of pharmaceutical
materials. John Wiley & Sons Inc.; 2017. p. 1e21.

198

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

REVIEW ARTICLE

[6] Ticehurst MD, Marziano I. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design. J Pharm Pharmacol 2015;
67:782e802.
[7] Hlinak AJ, Kuriyan K, Morris KR, Reklaitis GV, Basu PK.
Understanding critical material properties for solid dosage
form design. J Pharm Innov 2006;1:12e7.
[8] Charoo NA. Critical excipient attributes relevant to solid
dosage formulation manufacturing. J Pharm Innov 2020;15:
163e81.
[9] Leane M, Pitt K, Reynolds G. Manufacturing Classiﬁcation
System (MCS) Working Group. A proposal for a drug
product manufacturing classiﬁcation system (MCS) for oral
solid dosage forms. Pharmaceut Dev Technol 2015;20:
12e21.
[10] Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing process. Adv
Drug Deliv Rev 2001;48:91e114.
€
[11] HOrter
D, Dressman JB. Inﬂuence of physicochemical
properties on dissolution of drugs in the gastrointestinal
tract. Adv Drug Deliv Rev 2001;46:75e87.
[12] Vippagunta SR, Brittain HG, Grant DJW. Crystalline solids.
Adv Drug Deliv Rev 2001;48:3e36.
[13] ICH/FDA Guidance for industry. Q11 Development and
manufacture of drug substances. 2012.
[14] Saluja V, Sekhon BS. The regulation of pharmaceutical excipients. J Excipients Food Chem 2013;4:95e106.
[15] Brittain HG, Bogdanowich SJ, Bugay DE, DeVincentis J,
Lewen G, Newman AW. Physical characterization of pharmaceutical solids. Pharm Res (N Y) 1991;8:963e73.
[16] Suryanarayanan R, Byrn SR. Characterization of the solid
state. Adv Drug Deliv Rev 2001;48:1e136.
[17] Storey RA, Ym
en I, editors. Solid state characterization of
pharmaceuticals. Wiley-Blackwell; 2011.
[18] Law D, Zhou D. Solid-state characterization and techniques. In: Qiu Y, Chen Y, Zhang GGZ, Yu L, Mantri RV,
editors. Developing solid oral dosage forms: pharmaceutical theory and practice. 2 Ed. Academic Press; 2017.
p. 59e84.
[19] Brittain HG. Characterization of pharmaceutical compounds in the solid state. In: Ahuja S, Scypinski S, editors.
Handbook of modern pharmaceutical analysis. Academic
Press; 2001. p. 11e58.
[20] Vogt FG, Williams GR. Advanced approaches to effective
solid-state analysis: X-ray diffraction, vibrational spectroscopy, and solid-state NMR. Am Pharmaceut Rev 2010;13:
58e65.
[21] Chieng N, Rades T, Aaltonen J. An overview of recent
studies on the analysis of pharmaceutical polymorphs.
J Pharmaceut Biomed Anal 2011;55:618e44.
[22] Qiao Y, Qiao R, He Y, Shi C, Liu Y, Hao H, et al. Instrumental analytical techniques for the characterization of
crystals in pharmaceutics and foods. Cryst Growth Des
2017;17:6138e48.
[23] Rantanen J, Khinast J. The future of pharmaceutical
manufacturing sciences. J Pharmacol Sci 2015;104:3612e38.
[24] ICH Topic Q 1 A (R2). Stability testing of new drug substances and products. 2003.
[25] Huynh-Ba K, Dong MW. Stability studies and testing of
pharmaceuticals: an overview. LC-GC N Am 2020;38:
325e36.
[26] Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active
pharmaceutical ingredients: a comprehensive review.
J Excipients Food Chem 2010;1(3):3e26.
[27] Gupta KR, Pounikar AR, Umekar MJ. Drug excipient
compatibility testing protocols and charaterization: a review. Asian J Chem Sci 2019;6(3):1e22.
[28] Bhusnure OG, Gholve SB, Nitin K, Giram PS, Gaikwad VM,
Rajmane TM. Advanced approaches in solid-state analysis of
pharmaceuticals. Int J Pharm Pharmaceut Res 2015;5(1):1e29.

[29] Newman AW, Byrn SR. Solid-state analysis of the active
pharmaceutical ingredient in drug products. Drug Discov
Today 2003;8:898e905.
[30] Newman A, Wenslow R. Solid form changes during drug
development: good, bad, and ugly case studies. AAPS Open
2016;2:2.
[31] World Health Organization. Quality assurance of pharmaceuticals: a compendium of Guidelines and related
materials. Good manufacturing practices and inspection.
2nd ed., vol. 2. Geneva: World Health Organization;
2007.
[32] Lionberger RA, Lee SL, Lee L, Raw A, Lawrence X, Yu LX.
Quality by design: concepts for ANDAs. AAPS J 2008;10:
268e76.
[33] Lu J, Rohani S. Polymorphism and crystallization of active
pharmaceutical ingredients (APIs). Curr Med Chem 2009;
16:884e905.
[34] Doelker E. Crystalline modiﬁcations and polymorphism
changes during drug manufacture. Ann Pharm Fr 2002;60:
161e76.
[35] Baviskar SR, Patil SH. Solid phase transformation considerations during process development and manufacture of
solid oral dosage forms-A review. Int J PharmTech Res
2014;6:1963e9.
[36] Bauer J, Spanton S, Henry R, Quick J, Dziki W, Porter W,
et al. Ritonavir: an extraordinary example of conformational
polymorphism. Pharm Res (N Y) 2001;18:859e66.
[37] Censi R, Di Martino P. Polymorph impact on the bioavailability and stability of poorly soluble drugs. Molecules 2015;
20:18759e76.
[38] Gaisford S, Kett V, Haines P. Principles of thermal analysis
and calorimetry. 2nd ed. RSC Press; 2016.
[39] Müllertz A, Perrie Y, Rades T. Analytical techniques in the
pharmaceutical sciences. CRS Press; 2016.
[40] Craig DQM, Reading M. Thermal analysis of pharmaceuticals. Taylor & Francis; 2006.
[41] Stodghill SP. Thermal analysis e a review of techniques and
applications in the pharmaceutical sciences. Am Pharmaceut Rev 2010;13(2):29e36.
[42] Monajjemzadeh F, Ghaderi F. Thermal analysis methods in
pharmaceutical quality control. J Mol Pharm Org Process
Res 2015;3(1):e121.
[43] Gabbott P. Principles and applications of thermal analysis.
Blackwell Pub; 2007.
[44] Lin SY. An overview of advanced hyphenated techniques
for simultaneous analysis and characterization of polymeric materials. Crit Rev Solid State Mater Sci 2016;41:
482e530.
[45] Stieger N, Aucamp ME, Zhang SW, De Villiers MM. Hotstage optical microscopy as an analytical tool to understand
solid-state changes in pharmaceutical materials. Am Pharmaceut Rev 2012;15(3):32e6.
[46] Kumar A, Singh P, Nanda A. Hot stage microscopy and its
applications in pharmaceutical characterization. Appl
Microsc 2020;50. article 12.
[47] Hashimoto K, Badarla VR, Kawai A, Ideguchi T. Complementary vibrational spectroscopy. Nat Commun 2019;10:
4411.
[48] Bunaciu A, Aboul-Enein H, Hoang VD, editors. Vibrational
spectroscopy applications in biomedical. Pharmaceutical
and food sciences. Elsevier; 2020.
[49] Muro CK, Doty KC, Bueno J, Hal
amkov
a L, Lednev IK.
Vibrational spectroscopy: recent developments to revolutionize forensic science. Anal Chem 2015;87:306e27.
[50] Rohman A, Windarsih A, Lukitaningsih E, Raﬁ M,
Betania K, Fadzillah NA. The use of FTIR and Raman
spectroscopy in combination with chemometrics for analysis of biomolecules in biomedical ﬂuids: a review. Biomed
Spectrosc Imag 2019;8:55e71.
[51] Wartewig S, Neubert RH. Pharmaceutical applications of
Mid-IR and Raman spectroscopy. Adv Drug Deliv Rev 2005;
57:1144e70.

[52] Aaltonen J, Gordon KC, Strachan CJ, Rades T. Perspectives
in the use of spectroscopy to characterize pharmaceutical
solids. Int J Pharm 2008;364:159e69.
[53] Heinz A, Strachan CJ, Gordon KC, Rades T. Analysis of solidstate transformations of pharmaceutical compounds using
vibrational spectroscopy. J Pharm Pharmacol 2009;61:971e88.
[54] Deidda R, Sacre PY, Clavaud M, Coïc L, Avohou H,
Hubert P, et al. Vibrational spectroscopy in analysis of
pharmaceuticals:Critical review of innovative portable and
handheld NIR and Raman spectrophotometers. Trends
Anal Chem 2019;114:251e9.
[55] Bunaciu AA, Aboul-Enein HY. Vibrational spectroscopy
applications in DrugAnalysis. In: Lindon JC, Tranter GE,
Koppenaal DW, editors. Encyclopedia of spectroscopy and
spectrometry. 3rd ed. Elsevier; 2017. p. 575e81.
[56] Bunaciu AA, Aboul-Enein HY. Adulterated drug analysis
using FTIR spectroscopy. Appl Spectrosc Rev 2020. http://
dx.doi.org/10.1080/05704928.2020.1811717.
[57] Morisseau KM, Rhodes CT. Pharmaceutical uses of nearinfrared spectroscopy. Drug Dev Ind Pharm 1995;21:
1071e90.
[58] Franklin EB. Theory and principles of near infrared spectroscopy. Spectrosc Eur 2002;14:12e8.
[59] Gabriele R. Near-infrared spectroscopy and imaging: basic
principles and pharmaceutical applications. Adv Drug
Deliv Rev 2005;57:1109e43.
[60] Jamr
ogiewicz M. Application of the near-infrared spectroscopy in the pharmaceutical technology. J Pharmaceut
Biomed Anal 2012;66:1e10.
[61] Strachan CJ, Taday PF, Newnham DA, Gordon KC,
Zeitler JA, Pepper M, et al. Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and
crystallinity. J Pharmacol Sci 2005;94:837e46.
[62] Zeitler JA, Taday PF, Newnham DA, Pepper M, Gordon KC,
Rades T. Terahertz pulsed spectroscopy and imaging in the
pharmaceutical setting-A review. J Pharm Pharmacol 2007;
59:209e23.
[63] Shen YC. Terahertz pulsed spectroscopy and imaging for
pharmaceutical applications: a review. Int J Pharm 2011;417:
48e60.
[64] Haaser M, Gordon KC, Strachan CJ, Rades T. Terahertz
pulsed imaging as an advanced characterisation tool for
ﬁlm coatings-A review. Int J Pharm 2013;457:510e20.
[65] Bawuah P, Markl D, Farrell D, Evans M, Portieri A,
Anderson A, et al. Terahertz-based porosity measurement
of pharmaceutical tablets: a tutorial. J Infrared, Millim
Terahertz Waves 2020;41:450e69.
[66] Alves-Lima D, Song J, Li X, Portieri A, Shen Y, Zeitler JA,
et al. Review of Terahertz pulsed imaging for pharmaceutical ﬁlm coating analysis. Sensors 2020;20(5):1441.
[67] Zhang R, Liu S, Jin H, Luo Y, Zheng Z, Gao F, et al.
Noninvasive electromagnetic wave sensing of glucose.
Sensors 2019;19(5):1151.
[68] Das R, Eaqub A, Hamid A, Bee S. Current applications of xray powder diffraction-A review. Rev Adv Mater Sci 2014;
38:95e109.
[69] Bunaciu AA, Udristioiu EG, Aboul-Enein HY. X-Ray
diffraction: instrumentation and applications. Crit Rev Anal
Chem 2015;45:289e99.
[70] Randall C, Rocco W, Ricou P. XRD in pharmaceutical
analysis: a versatile tool for problem-solving. Am Pharmaceut Rev 2010;13(6):52e9.
[71] Brittain HG. X-ray diffraction III: pharmaceutical applications. Spectroscopy 2001;16(7):14e8.
[72] Anwar J. Pharmaceuticals: Design and development of drug
delivery systems. In: Chung FH, Smith DK, editors. Industrial applications of X-ray diffraction. Marcel Dekker; 2000.
p. 539e53.
[73] Widjonarko NE. Introduction to advanced X-ray diffraction
techniques for polymeric thin ﬁlms. Coatings 2016;6:54.
[74] https://www.physics.upenn.edu/~heiney/datasqueeze/
basics.html.

199

[75] Aitipamula S, Vangala VR. X-Ray crystallography and
its role in understanding the physicochemical properties
of pharmaceutical cocrystals. J Indian Inst Sci 2017;97:
227e43.
[76] Bond A. Pharmaceutical crystallography: a guide to structure and analysis. RSC Pub; 2019.
[77] Thakral NK, Zanon RL, Kelly RC, Thakral S. Applications of
powder X-ray diffraction in small molecule pharmaceuticals: achievements and aspirations. J Pharmacol Sci 2018;
107:2969e82.
[78] Caira MR. Current applications of powder x-ray diffraction
in drug discovery and development. Am Pharmaceut Rev
2014;17:54.
[79] Litteer B, Beckers D. Increasing application of X-ray powder
diffraction in the pharmaceutical industry. Am Lab 2005;37:
22e4.
[80] Ivanisevic I, McClurg RB, Schields PJ. Uses of X-ray powder
diffraction in the pharmaceutical industry. In: Gad SC, editor. Pharmaceutical sciences encyclopedia: drug discovery,
development, and manufacturing. John Wiley & Sons; 2010.
p. 1e42.
[81] Patel KN, Patel JK, Patel MP, Rajput GC, Patel HA. Introduction to hyphenated techniques and their applications in
pharmacy. Pharma Methods 2010;1(1):2e13.
[82] Singh S, Handa T, Narayanam M, Sahu A, Junwal M,
Shah RP. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities
and degradation products. J Pharmaceut Biomed Anal 2012;
69:148e73.
[83] Joshi RR, Gupta KR, Patil SS. Hyphenated technique-A
boon to analytical world. Int J Pharma Sci Res 2012;3:
4184e91.
[84] Usman Md, Badgujar SR, Shaikh TY. Hyphenated techniques of drug analysis. Scholars Acad J Pharm 2017;6:
263e72.
[85] Sarker SD, Nahar L. Hyphenated techniques and their applications in natural products analysis. Methods Mol Biol
2012;864:301e40.
[86] Phalke PL, Kavade S. Review on hyphenated techniques.
Int J Chem Stud 2013;1:157e65.
[87] Mulgund SV, Chitre TS, Mallade PS, Bariwal JB, Jain KS.
Hyphenated techniques in analytical world. Indian J Pharm
Edu Res 2008;42:393e401.
[88] Ermer J, Vogel M. Applications of hyphenated LC-MS
techniques in pharmaceutical analysis. Biomed Chromatogr
2000;14:373e83.
[89] Pan C, Liu F, Motto M. Identiﬁcation of pharmaceutical
impurities in formulated dosage forms. J Pharmacol Sci
2011;100:1228e59.
[90] Mirabella FM. Simultaneous differential scanning calorimetry (DSC) and infrared spectroscopy using an infrared
microsampling accessory (IRMA) and FT-IR. Appl Spectrosc 1986;40:417e20.
[91] Johnson DJ, Compton DAC, Canale PL. Applications of
simultaneous DSC/FTIR analysis. Thermochim Acta 1992;
195:5e20.
[92] Giron D. Applications of thermal analysis and coupled
techniques in pharmaceutical industry. J Therm Anal Calorim 2002;68:335e57.
[93] Schindler A, Neumann G, Rager A, Füglein E, Blumm J,
Denner T. A novel direct coupling of simultaneous thermal
analysis (STA) and Fourier transform-infrared (FT-IR)
spectroscopy. J Therm Anal Calorim 2013;113:1091e102.
[94] Spragg R. Combining FTIR microspectroscopy with differential scanning calorimetry. Analusis 2000;28:64e7.
[95] Materazzi S. Thermogravimetry-infrared spectroscopy (TGFTIR) coupled analysis. Appl Spectrosc Rev 1997;32:
385e404.
[96] Pasch H. Hyphenated separation techniques for complex
polymers. Polym Chem 2013;4:2628e50.
[97] Wolfender JL, Queiroz EF, Hostettmann K. The importance
of hyphenated techniques in discovery of new lead

REVIEW ARTICLE

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

200
REVIEW ARTICLE

[98]

[99]

[100]
[101]

[102]

[103]
[104]

[105]

[106]

[107]
[108]
[109]
[110]
[111]
[112]
[113]

[114]

[115]

[116]

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

compounds from nature. Expet Opin Drug Discov 2006;1:
237e60.
Pan C, Liu F, Ji Q, Wang W, Drinkwater D, Vivilecchia R.
The use of LC/MS, GC/MS, and LC/NMR hyphenated
techniques to identify a drug degradation product in
pharmaceutical development. J Pharmaceut Biomed Anal
2006;40:581e90.
Lin SY, Wang SL. Advances in simultaneous DSC-FTIR
microspectroscopy for rapid solid-state chemical stability
studies: some dipeptide drugs as examples. Adv Drug Deliv
Rev 2012;64:461e78.
Deokate U, Gorde AM. Forced degradation and stability
testing: strategies and analytical perspectives. Int J Pharmaceut Sci Rev Res 2014;42:242e50.
Tanna S, Ogwu J, Lawson G. Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future
perspectives. Clin Chem Lab Med 2020;58:643e63.
Menard N, Menard K. Hyphenated techniques in thermal
analysis. In: Meyers RA, editor. Encyclopedia of analytical
chemistry: applications, theory and instrumentation. John
Wiley & Sons; 2018. p. 1e10.
Menard KP, Spragg R, Johnson G, Sellman C. Hyphenation:
the next step in thermal analysis. Am Lab 2010;42:21e3.
Leyva-Porras C, Cruz-Alcantar P, Espinosa-Solís V, Martínez-Guerra E, Balderrama C, Martínez IC, et al. Application
of differential scanning calorimetry (DSC) and modulated
differential scanning calorimetry (MDSC) in food and drug
industries. Polymers 2019;12(1):5.
Koberstein JT, Gancarz I, Clarke TC. The effects of
morphological transitions on hydrogen bonding in
polyurethanes: preliminary results of simultaneous DSCFTIR experiments. J Polym Sci B Polym Phys 1986;24:
2487e98.
Dugan G, McCarty JD, Friant RJ. The application of combined differential scanning calorimetry-mass spectrometry
(DSC-MS) to the study of thermal and oxidative decompositions. In: Porter RS, Johnson JF, editors. Analytical
calorimetry. Springer; 1970. p. 417e27.
Yoshida H, Kinoshita R, Teramoto Y. Development of the
simultaneous thermal analysis/X-ray scattering measurement system. Thermochim Acta 1995;264:173e83.
Keller G, Lavigne F, Forte L, Andrieux K, Dahim M,
Loisel C, et al. DSC and X-Ray diffraction coupling. J Therm
Anal Calorim 1998;51:783e91.
Degamber B, Winter D, Tetlow J, Teagle M, Fernando GF.
Simultaneous DSC/FTIRS/TMA. Meas Sci Technol 2004;15:
L5e10.
Jasco Co. Introduction of new DLATGS detector for IRT5000/7000 infrared microscope. https://www.jasco.pl/wpcontent/uploads/2013/01/260MT0239_E.pdf.
Lin SY, Lin CC. One-step real-time food quality analysis by
simultaneous DSC-FTIR microspectroscopy. Crit Rev Food
Sci Nutr 2016;56:292e305.
Lin SY, Tsay WJ, Chen YL, Lee CJ. Application of a new
micro FTIR/DSC technique to the study of curing kinetics of
silicone elastomer. J Contr Release 1994;31:277e82.
Lin SY, Liao CM, Hsiue GH. A reﬂectance FTIR/DSC
microspectroscopic study of nonisothermal kinetics of anhydride formation in Eudragit L-100 ﬁlms. Polym Degrad
Stabil 1995;47:299e303.
Lin SY, Liao CM, Hsiue GH. Thermal-dependent anhydride formation of Eudragit L-100 ﬁlms determined by
reﬂectance FTIR/DSC microspectroscopy. Polymer 1995;36:
3239e41.
Lin SY, Liao CM, Hsiue GH. Isothermal kinetics of anhydride formation in Eudragit L-100 ﬁlms determined by
reﬂectance FTIR/DSC microspectroscopy. Polymer 1996;37:
269e73.
Lin SY, Yu HL, Li MJ. Formation of six-membered cyclic
anhydrides by thermally induced intramolecular ester
condensation in Eudragit E ﬁlm. Polymer 1999;40:
3589e93.

[117] Lin SY, Yu HL. Thermal stability of methacrylic acid copolymers of Eudragits L, S and L 30 D and the acrylic acid
polymer of carbopol. J Polym Sci Polym Chem 1999;37:
2061e7.
[118] Lin SY, Yu HL. Microscopic Fourier transform infrared/
differential scanning calorimetry system used to study the
different thermal behaviors of polymethacrylate copolymers of Eudragits RS, RL, E 30D or E. J Appl Polym Sci
2000;78:829e35.
[119] Lin SY, Cheng WT, Wei YS, Lin HL. DSC-FTIR microspectroscopy used to investigate the thermal-induced
intramolecular cyclic anhydride formation between Eudragit E and PVA copolymer. Polym J 2011;43:577e80.
[120] Lin SY, Laio CM, Liang RC. Use of microscopic FT-IR/DSC
combined system for the study of glass transition temperature of polymers. Polym J 1995;27:201e4.
[121] Steinberg SM, Bada JL. Peptide decomposition in the
neutral pH region via the formation of diketopiperazines.
J Org Chem 1983;48:2295e8.
[122] Lai MC, Topp EM. Solid-state chemical stability of proteins
and peptides. J Pharmacol Sci 1999;88:489e500.
[123] Chang LL, Pikal MJ. Mechanisms of protein stabilization in
the solid state. J Pharmacol Sci 2009;98:2886e908.
[124] Manning MC, Chou DK, Murphy BM, Payne RW,
Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res (N Y) 2010;27:544e75.
[125] Zapadka KL, Becher FJ, Gomes Dos Santos AL, Jackson SE.
Factors affecting the physical stability (aggregation) of
peptide therapeutics. Interface Focus 2017;7(6):20170030.
[126] Leung SS, Grant DJW. Solid-state stability studies of model
dipeptides:
aspartame
and
aspartylphenylalanine.
J Pharmacol Sci 1997;86:64e71.
[127] Toporisic R, Mlakar A, Hvala J, Prislan I, Zupancic-Kralj L.
Identiﬁcation of new impurities of enalapril maleate on
oxidation in the presence of magnesium monoperoxyphthalate. J Pharmaceut Biomed Anal 2010;52:294e9.
[128] Hailu SA, Bogner RH. Effect of the pH grade of silicates on
chemical stability of coground amorphous quinapril hydrochloride and its stabilization using pH-modiﬁers.
J Pharmacol Sci 2009;98:3358e72.
[129] Shaﬁq S, Shakeel F, Khar RK. Enhanced stability of ramipril
in nanoemulsion containing cremophor-EL: a technical
note. AAPS Pharm Sci Tech 2008;9:1097e101.
[130] Wang SL, Lin SY, Chen TF. Thermal-dependent dehydration process and intramolecular cyclization of lisinopril
dihydrate in the solid state. Chem Pharm Bull 2000;48:
1890e3.
[131] Wang SL, Lin SY, Chen TF. Reaction kinetics of solid-state
cyclization of enalapril maleate investigated by isothermal
FT-IR microscopic system. Chem Pharm Bull 2001;49:402e6.
[132] Lin SY, Wang SL, Chen TF, Hu TC. Intramolecular cyclization of diketopiperazine formation in solid-state enalapril
maleate studied by thermal FT-IR microscopic system. Eur J
Pharm Biopharm 2002;54:249e54.
[133] Lin SY, Cheng YD. Simultaneous formation and detection
of the reaction products of solid-state aspartame sweeteener by FT-IR/DSCmicroscopic system. Food Addit Contam 2000;17:821e7.
[134] Cheng YD, Lin SY. Isothermal FT-IR microspectrosopic
studies on the stability kinetics of solid-state intramolecular
cyclization of aspartame sweetener. J Agric Food Chem
2000;48:631e5.
[135] Widjaja E, Lim GK, Cho PS, Tan S. Multivariate data
analysis as a tool to investigate the reaction kinetics of
intramolecular cyclization of enalapril maleate studied by
isothermal and non-isothermal FT-IR microscopy. Eur J
Pharmaceut Sci 2007;32:349e436.
[136] Tan WJ, Widjaja E. Multivariate chemometric approach to
thermal solid-state FT-IR monitoring of pharmaceutical
drug compound. J Pharmacol Sci 2008;97:3379e87.
[137] Widjaja E, Tan WJ. Kinetics of lisinopril intramolecular
cyclization in solid phase monitored by Fourier transform
infrared microscopy. Appl Spectrosc 2008;62:889e94.

[138] Hsu CH, Lin SY. Rapid examination of the kinetic process of
intramolecular lactamization of gabapentin using DSCFTIR. Thermochim Acta 2009;486:5e10.
[139] Singhal D, Curatolo W. Drug polymorphism and dosage
form design: a practical perspective. Adv Drug Deliv Rev
2004;56(3):335e47.
[140] Zhou Y, Wang J, Xiao Y, Wang T, Huang X. The effects of
polymorphism on physicochemical properties and pharmacodynamics of solid drugs. Curr Pharmaceut Des 2018;
24:2375e82.
[141] Ainuroﬁq A, Dinda KE, Pangestika MW, Himawati U,
Wardhani WD, Sipahutar YT. The effect of polymorphism
on active pharmaceutical ingredients: a review. Int J Res
Pharm Sci 2020;11:1621e30.
[142] Karazniewicz-Łada
M,
Bąba
K,
Dolatowski
F,
Dobrowolska A, Rakicka M. The polymorphism of statins
and its effect on their physicochemical properties. Polim
Med 2018;48(2):77e82.
[143] Blandizzi C, Viscomi GC, Scarpignato C. Impact of
crystal polymorphism on the systemic bioavailability of
rifaximin, an antibiotic acting locally in the gastrointestinal
tract, in healthy volunteers. Drug Des Dev Ther 2015;9:1e11.
[144] Zhang GGZ, Law D, Schmitt EA, Qiu Y. Phase transformation considerations during process development and
manufacture of solid oral dosage forms. Adv Drug Deliv
Rev 2004;56:371e90.
[145] Saifee M, Inamdar N, Dhamecha DL, Rathi AA. Drug
polymorphism: a review. Int J Health Res 2009;2:291e306.
[146] Higashi K, Ueda K, Moribe K. Recent progress of structural
study of polymorphic pharmaceutical drugs. Adv Drug
Deliv Rev 2017;117:71e85.
[147] Wang SL, Lin SY, Wei YS. Transformation of metastable
forms of acetaminophen studied by thermal Fourier transform infrared (FT-IR) microspectroscopy. Chem Pharm Bull
2002;50:153e6.
[148] Lin SY, Wang SL, Cheng YD. Thermally induced structural
changes of acetaminophen in phase transition between the
solid and liquid states monitored by combination analysis
of FT-IR/DSC microscopic system. J Phys Chem Solid 2000;
61:1889e93.
[149] Lin SY, Cheng WT, Wang SL. Thermodynamic and kinetic
characterization of polymorphic transformation of famotidine during grinding. Int J Pharm 2006;318:86e91.
[150] Wang SL, Wong YC, Cheng WT, Lin SY. A continuous
process for solid-state dehydration, amorphization and
recrystallization of metoclopramide HCL monohydrate
studied by simultaneous DSC-FTIR microspectroscopy.
J Therm Anal Calorim 2011;104:261e4.
[151] Lin SY. Molecular perspectives on solid-state phase transformation and chemical reactivity of drugs: metoclopramide
as an example. Drug Discov Today 2015;20:209e22.
[152] Kao CU, Huang HH, Huang YT, Lin LH, Lin SY. Thermoanalytical and spectroscopic studies on amorphization
and phase transition of amorphous indomethacin prepared
by two melt-cooling processes. Sci Lett J 2015;4:148.
[153] Lin HL, Chi YT, Huang YT, Kao CY, Lin SY. DSC-FTIR
combined approaches used to simultaneously prepare/
determine the amorphous solid dispersions of indomethacin/Soluplus in real-time. EC Pharm Sci 2015;2:183e93.
[154] Lin SY, Chien JL. In vitro simulation of solid-solid dehydration, rehydration and solidiﬁcation of trehalose dihydrate using thermal and vibrational spectroscopic
techniques. Pharm Res (N Y) 2003;20:1926e31.
[155] Cheng WT, Lin SY. Processes of dehydration and rehydration of rafﬁnose pentahydrate investigated by thermal
analysis and FT-IR/DSC microscopic system. Carbohydr
Polym 2006;64:212e7.
[156] Greco K, Bogner R. Crystallization of amorphous indomethacin during dissolution: effect of processing and
annealing. Mol Pharm 2010;7:1406e18.
[157] Lin SY, Cheng WT. The use of hot-stage microscopy and
thermal micro-Raman spectroscopy in the study of phase

[158]

[159]

[160]

[161]

[162]
[163]

[164]

[165]

[166]

[167]

[168]

[169]

[170]

[171]

[172]
[173]
[174]

[175]

201

transformation of metoclopramide HCl monohydrate.
J Raman Spectrosc 2012;43:1166e70.
Lin SY, Cheng WT, Wang SL. Thermal micro-Raman
spectroscopic study of polymorphic transformation of
famotidine under different compression pressures. J Raman
Spectrosc 2007;38:39e43.
Cheng WT, Lin SY, Li MJ. Raman microspectroscopic
mapping or thermal system used to investigate millinginduced solid-state conversion of famotidine polymorphs.
J Raman Spectrosc 2007;38:1595e601.
Wang SL, Lin SY, Chen TF, Chuang CH. Solid-state transcis isomerization of captopril determined by thermal
Fourier transform infrared (FT-IR) microspectroscopy.
J Pharmacol Sci 2001;90:1034e9.
Serajuddin AT, Thakur AB, Ghoshal RN, Fakes MG,
Ranadive SA, Morris KR, et al. Selection of solid dosage
form composition through drug-excipient compatibility
testing. J Pharmacol Sci 1999;88:696e704.
Patel JP, Ahir K, Patel V, Manami L, Patel C. Drug excipient
compatibility studies: ﬁrst step for dosage form development. Pharma Innov J 2015;4(5):14e20.
Lin SY, Liao CM, Hsiue GH, Liang RC. Study of theophylline-Eudragit L mixture by using a combined system of
microscopic Fourier transform infrared spectroscopy and
differential scanning calorimetry. Thermochim Acta 1995;
245:153e66.
Wang SL, Lin SY, Chen TF, Cheng WT. Eudragit E accelerated the diketopiperazine (DKP) formation of enalapril
maleate determined by thermal FTIR microspectroscopic
technique. Pharm Res (N Y) 2004;21:2127e32.
Hwang DF, Hsieh TF, Lin SY. One-step simultaneous differential scanning calorimetry-FTIR microspectroscopy to
quickly detect continuous pathways in the solid-state
glucose/asparagine Maillard reaction. J AOAC Int 2016;96:
1362e4.
Cheng WT, Wang SL, Lin SY. Thermal FT-IR microspectroscopy for rapid detection of solid-state ion-exchange
reaction between metoclopramide HCl monohydrate and
potassium bromide. Analyst 2011;136:1036e40.
Huang YT, Liao HF, Wang SL, Lin SY. Thermal Fourier
transform infrared technique quickly detects an early onset
of glycation-induced conformational changes of human
serum albumin. Pharm Anal Acta 2016;7:512.
Williams HD, Trevaskis NL, Charman SA, Shanker RM,
Charman WN, Pouton CW, et al. Strategies to address low
drug solubility in discovery and development. Pharmacol
Rev 2013;65:315e499.
Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S.
Formulation design for poorly water-soluble drugs based
on biopharmaceutics classiﬁcation system: basic approaches and practical applications. Int J Pharm 2011;420:
1e10.
Zhang X, Xing H, Zhao Y, Ma Z. Pharmaceutical dispersion
techniques for dissolution and bioavailability enhancement
of poorly water-soluble drugs. Pharmaceutics 2018;23(3):74.
10.
Varshosaz J, Ghassami E, Ahmadipour S. Crystal engineering for enhanced solubility and bioavailability of
poorly soluble drugs. Curr Pharmaceut Des 2018;24:
2473e96.
Schultheiss N, Newman A. Pharmaceutical cocrystals and
their physicochemical properties. Cryst Growth Des 2009;9:
2950e67.
Karagianni A, Malamatari M, Kachrimanis K. Pharmaceutical cocrystals: new solid phase modiﬁcation approaches
for the formulation of APIs. Pharmaceutics 2018;10(1):18.
Karimi-Jafari M, Padrela L, Walker GM, Croker DM.
Creating cocrystals: a review of pharmaceutical cocrystal
preparation routes and applications. Cryst Growth Des
2018;18:6370e87.
Panzade PS, Shendarkar GR. Pharmaceutical cocrystal: a
game changing approach for the administration of old

REVIEW ARTICLE

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

202
REVIEW ARTICLE

[176]
[177]
[178]
[179]
[180]
[181]
[182]

[183]

[184]
[185]
[186]
[187]
[188]

[189]

[190]

[191]
[192]

JOURNAL OF FOOD AND DRUG ANALYSIS 2021;29:182e202

drugs in new crystalline form. Drug Dev Ind Pharm 2020;46:
1559e68.
Trask AV. An overview of pharmaceutical cocrystals as intellectual property. Mol Pharm 2017;4:301e9.
Jayram P, Sudheer P. Pharmaceutical co-crystals: a systematic review. Int J Pharm Invest 2020;10(3):246e52.
US Food and Drug Administration (FDA). Guidance for
industry regulatory classiﬁcation of pharmaceutical Cocrystals. 2018.
European Medicines Agency (EMA). Reﬂection paper on
the use of cocrystals of active substances in medicinal
products. 2015.
Gadade DD, Pekamwar SS. Pharmaceutical cocrystals:
regulatory and strategic aspects, design and development.
Adv Pharm Bull 2016;6:479e94.
Izutsu KI, Koide T, Takata N, Ikeda Y, Ono M, Inoue M,
et al. Characterization and quality control of pharmaceutical cocrystals. Chem Pharm Bull 2016;64:1421e30.
Peltonen L. Practical guidelines for the characterization and
quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry. Adv Drug Deliv Rev
2018;131:101e15.
Kojima T, Tsutsumi S, Yamamoto K, Ikeda Y, Moriwaki T.
High-throughput cocrystal slurry screening by use of in situ
Raman microscopy and multi-well plate. Int J Pharm 2010;
399:52e9.
Lu E, Rodríguez-Hornedo N, Suryanarayanan R. A rapid
thermal method for cocrystal screening. Cryst Eng Comm
2008;10:665e8.
Zalte AG, Saudagar RB. Advanced techniques in preparation of cocrystals. Int J Sci Progr Res 2015;12:32e5.
Douroumis D, Ross SA, Nokhodchi A. Advanced methodologies for cocrystal synthesis. Adv Drug Deliv Rev 2017;
117:178e95.
Pindelska E, Sokal A, Kolodziejski W. Pharmaceutical cocrystals, salts and polymorphs: advanced characterization
techniques. Adv Drug Deliv Rev 2017;117:111e46.
Wu TK, Lin SY, Lin HL, Huang YT. Simultaneous DSCFTIR microspectroscopy used to screen and detect the cocrystal formation in real time. Bioorg Med Chem Lett 2011;
21:3148e51.
Zhang GC, Lin HL, Lin SY. Thermal analysis and FTIR
spectral curve-ﬁtting investigation of formation mechanism
and stability of indomethacin-saccharin cocrystals via solidstate grinding process. J Pharmaceut Biomed Anal 2012;66:
162e9.
Hsu PC, Lin HL, Wang SL, Lin SY. Solid-state thermal
behavior and stability studies of theophylline-citric acid
cocrystals prepared by neat cogrinding or thermal treatment. J Solid State Chem 2012;192:238e45.
Lin HL, Hsu PC, Lin SY. Theophylline-citric acid co-crystals
easily induced by DSC-FTIR microspectroscopy or different
storage conditions. Asian J Pharm Sci 2013;8:19e27.
Lin HL, Wu TK, Lin SY. Screening and characterization of
cocrystal formation of metaxalone with short-chain

[193]

[194]

[195]

[196]

[197]

[198]
[199]
[200]
[201]

[202]

[203]
[204]
[205]
[206]

[207]

dicarboxylic acids induced by solvent-assisted grinding
approach. Thermochim Acta 2014;575:313e21.
Lin HL, Zhang GC, Huang YT, Lin SY. An investigation of
indomethacin-nicotinamide cocrystal formation induced by
thermal stress in the solid or liquid state. J Pharmacol Sci
2014;103:2386e95.
Lin HL, Zhang GC, Lin SY. Real-time co-crystal screening
and formation between indomethacin and saccharin via
DSC analytical technique or DSC-FTIR microspectroscopy.
J Therm Anal Calorim 2015;120:679e87.
Lin SY, Lin HL, Hung RY, Huang YT, Kao CY. Effect of
Povacoat or Soluplus on solid-state characterization of
indomethacin-nicotinamide co-crystal formation. Pharm
Anal Acta 2015;6:402.
Lin HL, Huang YT, Lin SY. Spectroscopic and thermal approaches to investigate the formation mechanism of
piroxicamesaccharin co-crystal induced by liquid-assisted
grinding or thermal stress. J Therm Anal Calorim 2016;123:
2345e56.
Lin SY, Lin HL, Chi YT, Hung RY, Huang YT, Hsieh WH,
et al. Inﬂuence of Soluplus on solid-state properties and
physical stability of indomethacin-saccharin co-crystal formation prepared by air-drying process. J Pharm Innov 2016;
11:109e19.
Lin SY. Mechanochemical approaches to pharmaceutical
cocrystal formation and stability analysis. Curr Pharmaceut
Des 2016;22:5001e18.
Lin SY. Simultaneous screening/detection of pharmaceutical co-crystals by one-step DSC-FTIR microspectroscopic
technique. Drug Discov Today 2017;22:718e28.
Basavoju S, Bostr€
om D, Velaga SP. Indomethacin-saccharin
cocrystal: design, synthesis and preliminary pharmaceutical
characterization. Pharm Res (N Y) 2008;25:530e41.
Padrela L, Rodrigues MA, Velaga SP, Matos HA, de
Azevedo EG. Formation of indomethacin-saccharin cocrystals using supercritical ﬂuid technology. Eur J Pharmaceut Sci 2009;38:9e17.
Ali HRH, Alhalaweh A, Mendes NFC, Ribeiro-Claro P,
Velaga SP. Solid-state vibrational spectroscopic investigation of cocrystals and salt of indomethacin. Cryst Eng
Comm 2012;14:6665e74.
Taleuzzaman M, Gilani SJ. Brief on -Hyphenated methods
of HPLC for determining the presence of solutes. Chron
Pharm Sci 2017;1(1):35e42.
Phalke P, Kavade S. Review on hyphenated techniques. Int J
Chem Studies 2013;1:157e65.
Badyal PN, Sharma C, Navdeep K, Shankar R, Pandey A,
Rawal RK. Analytical techniques in simultaneous estimation:
an overview. Austin J Anal Pharm Chem 2015;2(2):1037.
Kind T, Fiehn O. Hardware and software challenges for the
near future: structure elucidation concepts via hyphenated
chromatographic techniques. LC-GC N Am 2008;26(2):
176e87.
Beccaria M, Cabooter D. Current developments in LC-MS
for pharmaceutical analysis. Analyst 2020;145:1129e57.

